Table 1.
Baseline Characteristics of KHARMA Participants (n=193)
| Variable | MI group (n=97) | HPP group (n=96) | Total (n=193) |
|---|---|---|---|
| Age | |||
| Mean (SD) | 43.5 (9.2) | 44.1 (9.0) | 43.8 (9.1) |
| Number of years HIV-positive | |||
| Mean (SD)a | 8.6 (6.0) | 10.4 (6.5) | 9.5 (6.3) |
| Number of years on ARVs | |||
| Mean (SD) | 5.7 (4.9) | 6.8 (5.0) | 6.2 (5.0) |
| Ethnicity, n (%) | |||
| African American | 88 (90.7) | 91 (94.8) | 179 (92.7) |
| White | 6 (6.2) | 1 (1.0) | 7 (3.6) |
| Other | 3 (3.1) | 4 (4.2) | 7 (3.6) |
| Education, n(%) | |||
| <High school | 17 (17.5) | 21 (21.9) | 38 (19.7) |
| High school | 54 (55.7) | 49 (51.0) | 103 (53.4) |
| >High school | 26 (26.8) | 26 (27.1) | 52 (26.9) |
| Employment, n(%) | |||
| Employed | 16 (16.5) | 14 (14.6) | 30 (15.5) |
| Marital status, n (%) | |||
| Married | 5 (5.2) | 13 (13.5) | 18 (9.4) |
| Committed relationship | 21 (21.9) | 13 (13.5) | 34 (17.7) |
| Never married | 26 (27.1) | 27 (28.1) | 53 (27.6) |
| Separated/divorced/widowed | 44 (45.8) | 43 (44.8) | 87 (45.3) |
| Children, n(%) | |||
| Yesb | 86 (88.7) | 75 (78.1) | 161 (83.4) |
| Median, range | 3, 1-7 | 3, 1-9 | 3, 1-9 |
| Annual Income, n (%) | |||
| ≤$10,000 | 64 (69.6) | 62 (66.0) | 126 (67.7) |
| >$10,000 | 28 (30.4) | 32 (34.0) | 60 (32.3) |
| Sexual identity, n (%) | |||
| Heterosexual | 78 (80.4) | 72 (75.0) | 150 (77.7) |
| Gay, homosexual | 2 (2.1) | 3 (3.1) | 5 (2.6) |
| Bisexual | 5 (5.2) | 3 (3.1) | 8 (4.1) |
| None of above/unsure | 12 (12.4) | 18 (18.8) | 30 (15.5) |
| Sexually active (past 3 months), n (%) | |||
| Yes | 50 (51.5) | 52 (54.2) | 102 (51.5) |
| CD 4 count | |||
| Mean (SD),cn | 337.0 (267.4), 69 | 463.8 (388.2), 75 | 403.0 (340.6), 144 |
| Viral load (log10) | |||
| Mean (SD), n | 2.6 (1.0), 76 | 2.5 (1.0), 77 | 2.5 (1.0), 153 |
| Percent of prescribed doses taken | |||
| Mean (SD), n | 72.9 (35.8), 94 | 76.4 (32.6), 96 | 74.6 (34.2), 190 |
| AGAS (self-report adherence) | |||
| Mean (SD) | 20.5 (3.2) | 20.3 (3.1) | 20.4 (3.2) |
| Risk index score | |||
| Mean (SD) | 2.6 (2.8) | 3.0 (3.1) | 2.8 (2.9) |
a
t(188)=2.09, p=0.038.
b
χ2(1)=3.87, p=0.049.
c
t(131.9)=2.29, p=0.023, unequal variances.
KHARMA, Keeping Healthy and Active with Risk Reduction and Medication Adherence Project; AGAS, Antiretroviral General Adherence Scale; SD, standard deviation; ARVs, antiretrovirals.